Curanex Pharmaceuticals Inc (CURX) income statement
CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70−0.00 (-0.00%)
Close on Nov 18, 2026Market cap $7.37MP/E –Yield –
Curanex Pharmaceuticals Inc income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -72.1%
Financial strength
- Current ratio
- 17.84
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1102.4%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.90
- Dividend yield
- –
See a number that looks wrong?